Navidea Biopharmaceuticals Inc Beta
What is the Beta of Navidea Biopharmaceuticals Inc?
The Beta of Navidea Biopharmaceuticals Inc is 0.00
What is the definition of Beta?
BETA indicates whether a stock is more or less volatile than the market as a whole. A beta less than 1 indicates that the stock is less volatile than the market, while a beta more than 1 indicates that the stock is more volatile. Volatility is measured as the fluctuation of the price around the mean.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta of companies in the Health Care sector on NYSEMKT compared to Navidea Biopharmaceuticals Inc
What does Navidea Biopharmaceuticals Inc do?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Companies with beta similar to Navidea Biopharmaceuticals Inc
- Vision Marine Technologies has Beta of 0.00
- Ely Gold Royalties has Beta of 0.00
- Glacier Lake Resources has Beta of 0.00
- Magnum Mining and Exploration has Beta of 0.00
- Africa Opportunity Fund has Beta of 0.00
- Fulcrum Utility Services has Beta of 0.00
- Navidea Biopharmaceuticals Inc has Beta of 0.00
- Gullewa has Beta of 0.00
- S.A.L. Steel has Beta of 0.00
- Andina Acquisition III has Beta of 0.00
- Andina Acquisition III has Beta of 0.00
- Brilliant Acquisition has Beta of 0.00
- Indokem has Beta of 0.00